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DOUBLE AMEBIC AND KLEBSIELLA PNEUMONIAE LIVER ABSCESSES IN A
DIABETIC PATIENT WITH KLEBSIELLA MENINGITIS: CASE REPORT
Mei-Miao Eu a, Wen-Liang Yu b. aDepartment of Infection Control
Committee, Chi-Mei Medical Center, Tainan, Taiwan; bDepartment of
Intensive Care Medicine, Chi-Mei Medical Center, Tainan, Taiwan
Purpose: Amebic liver abscess is most common in tropical areas. Klebsiella
pneumoniae (KP) is a well-known pathogen of diabetic patients and can
frequently cause primary liver abscess and distant metastasis, resulting in
meningitis. We report a diabetic patient of KP meningitis associated with
double liver abscesses caused by KP and ameba.
Case report: A 55 year-old diabetic man was admitted due to consciousness
disturbance for 1 day. Intermittent fever, chills, headache, dizziness and
right leg pain were also noted for 1 week. There was no rhinorrhea, cough,
abdominal pain, vomiting or diarrhea. He was found general weakness and
progressive consciousness disturbance since the morning. The patient
became unarousable and poor sensation over left limb was noted. There
was no seizure or incontinence. Upon physical examination, GCS was
E2V1M4, and nuchal rigidity and Kussmaul’s respiration were found. Labora-
tory data showed hyperglycemia, ketonemia (2+) and metabolic acidosis. C-
reactive protein (CRP) was 243.7 mg/L. Brain CT showed no intracranial
hemorrhage. Lumbar puncture found an opening pressure of 27cmH2O and
yellowish cloudy CSF, which analysis showed pleocytosis with a WBC of
12,672/ml and elevated protein level (325 mg/dL). Fluid resuscitation and
antibiotic therapy with ceftriaxone were given. The blood and CSF cultures
yielded KP. The CT of the abdomen for survey identified two separated liver
abscesses (4.7 and 2.5 cm in size, respectively). Then pig-tail draining was
inserted into a large abscess and KP was isolated from the purulent pus.
Follow-up abdomen CT showed mild residual lesion (2.4 cm in size), yet
another abscess showed progressive enlargement (4.6 cm in size). Ameba
antibody was positive (1:32 titer). Ceftriaxone was given for 2 weeks. The
conscious disturbance and fever relieved gradually and CRP decreased to
92.1 mg/L. As fever subsided and consciousness became clear, he was dis-
charged after a total of 16 days for hospitalization.
Conclusions: We report a rare double liver abscesses caused KP and probably
ameba, respectively. Amebiasis should still be considered in areas with high
prevalence of primary KP liver abscess, if abscess shows untoward response
to antibiotic therapy.
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THE COMMERCIAL DENGUE NS1 AG STRIP AS A MARKER OF DENGUE
SEVERITY
Yu-Jung Tung, Chun-Yu Lin, Yen-Hsu Chen, Chung-Hao Huang. Division of
Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical
University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
Purpose: There were in vitro studies emphasizing the role of Dengue non-
structural protein 1 (NS1) on the pathogenesis of dengue hemorrhagic
fever(DHF). The relationship between the sensitivities of commercial NS1
antigen detection kit and dengue severity is controversial. We aim to eval-
uate the positivity of Dengue NS1 Ag STRIP (BioRad, Hercules, CA) on the
severity of dengue fever.
Methods: Adult patients with laboratory-confirmed dengue in a tertiary hos-
pital in Taiwan were enrolled during July 2009 to January 2012. The day of
illness onset was defined as day post illness onset 1 (DPO1). The patients
with Dengue NS1 Ag STRIP (NS1) tested and presenting during DPO 1 to
DPO 8 were analyzed. The severity of dengue was compared between NS1-
negative and -positive groups. DPO 1-3 was defined as early presentation
and DPO4-8 was defined as late presentation.
Results: During the study period, total 387 patients were enrolled for anal-
ysis. The overall sensitivity of Dengue NS1 Ag STRIP was 67.44%. 65.89% of
patients were in late presentation. The patient characteristics were not
different between early presentation and late presentation except chronic
kidney disease. Patients with Dengue NS1 Ag STRIP tested negative have
higher rate of plasma leakage, any bleeding, marked thrombocytopenia
(<50,000 cells/mL) and elevated aminotransferase than positive result
(PZ0.0017, 0.024, 0.0017, and 0.0015, respectively). These differencesamong patients in late presentation were more significant than in early pre-
sentation (early: late, PZ0.7573: 0.0001, 0.9904: 0.0027, 0.9458: 0.0002,
and 0.1582: 0.0122 respectively). We also found more patients with negative
Dengue NS1 Ag STRIP results having DHF/DSS(dengue shock syndrome) than
positive results among the group with late presentation.
Conclusion: In our study, patients with negative result of Dengue NS1 Ag
STRIP tend to be severe. Thus this NS1 rapid test needs to be used with
caution, especially among the patients in late presentation.
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THE USE OF STRUCTURAL CHARACTERISTICS OF GENETICS TO EARLY
DIAGNOSIS OF TUBERCULOSIS
Yupei Ku. Chiayi Chang Gung Memorial Hospital Infection Control
Committee, Taiwan
Purpose: Because of the slow growth of Mycobacterium tuberculosis, it usu-
ally takes more than one to three months for traditional culture and tradi-
tional identification. It is a definite distress for physicians, patients,
community prevention and public health management as a whole. In order
for doctors to be able to diagnose tuberculosis Mycobacterium, or Nontuber-
culous Mycobacteria to further implement appropriate disposal and treat-
ment, the use of Polymerase chain reaction(PCR), a molecular biology
technique used to amplify a specific DNA fragment is applied.
Methods: PCR is performed in vitro, and has brought in great benefits for the
diagnosis of tuberculosis. The test focused on Mycobacterium tuberculosis
insertion sequence IS6110 as target site for DNA replication (Sensitivity Z
85% and Specificity Z 97%)
Results: From January 2014 to September 2014, total 196 Mycobacterium acid
staining test positive specimens were taken for the TB-PCR test (polymerase
chain chain reaction)test. TB-PCR test positive stood for 72 (37%) while TB-
PCR detection of negative was 124 (63%). For TB-PCR test positive, the trace
culture result for Mycobacterium tuberculosis was 88% (63/72), non-tubercu-
lous mycobacteria 3% (2/72), negative 10% (7/72); TB-PCR tested negative
,trace culture result for Mycobacterium tuberculosis was 13% (16/124), non-
tuberculous mycobacteria 46% (57/124), negative 41% (51/124).
Conclusions: This molecular diagnostic technology is especially suitable for
the rapid diagnosis of sputum smear that was positive for acid-fast staining
patients, but due to the detection target as DNA, it is unable to distinguish
between whether the case is in the latency or active tuberculosis stage.
Therefore, it is recommended that the application be used in cases before
the early detection of anti-TB drugs, but not for follow-up treatment. For
those acid staining positive test was negative by PCR, chest X-ray and careful
observation of clinical symptoms should be taken into consideration to
determine the possibility of tuberculosis.
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CLINICAL MANIFESTATIONS, COURSES, AND OUTCOMES IN PATIENTS
WITH ANTI-INTERFERON-g AUTOANTIBODIES AND DISSEMINATED NON-
TUBERCULOUS MYCOBACTERIAL INFECTIONS
Chih-Yu Chi a, Chia-Hao Lin b, Mao-Wang Ho a, Cheng-Lung Ku b. aDivision of
Infectious Diseases, China Medical University Hospital, Taichung, Taiwan;
bGraduate Institute of Clinical Medical Science, Chang Gung University,
Taoyuan, Taiwan
Purpose: Anti-interferon-g (anti-IFN-g) autoantibodies-associated immuno-
deficiency is an emerging medical issue in Southeast Asia. In the present
study, we describe and discuss the clinical features and outcomes of patients
with such autoantibodies and disseminated non-tuberculous mycobacterial
(dNTM) infections.
Methods: We thoroughly reviewed the medical records of all our patients.
The identification of microorganisms and IFN-g autoantibodies was based
on the methods used in our previous study with a few modifications. All
data were calculated and analyzed using SPSS software.
Results: In this study, we included 33 adults with anti-IFN-g autoantibodies
and dNTM infections. No sex predominance was found. Most patients (90.9%)
were Minnan and the average age was 60.7 years. Fourteen patients had un-
derlying diseases, and eight patients exhibited concurrent co-infections.
Slow-growing NTMs were isolated more commonly than rapid-growing
NTMs. Lymphadenopathy (81.8%) was the most common clinical
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cutaneous manifestations not directly related to NTMs. There was no specific
time-sequence in the appearance of zoster, salmonellosis and NTM infec-
tions. Three different clinical courses were recorded and most of our pa-
tients (75.8%) required long-term anti-mycobacterial therapy.
Conclusions: Despite anti-mycobacterial therapy, the clinical course of most
patients with anti-IFN-g autoantibodies and dNTM infections is protracted
and recalcitrant. In addition to microbial infections, the other common clin-
ical presentations include neutrophilic dermatoses and T-cell/macrophage
linage-associated malignancies. In the future, further study is needed to
elucidate the characteristics of this disease.
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THE EFFICACY OF IMPLEMENT NATIONAL LATENT TUBERCULOSIS
INFECTION TREATMENT PROGRAM IN A REGIONAL HOSPITAL IN
SOUTHERN TAIWAN
Chun- hui Wu a, Wu Sun a, Tsung -Sheng Yang b, Ya- Ching Chang c, Hung
-Chun Chou c, Wen- hui Chen d, Yu-hsia Yang d. aInfection Control
Department, Paochien Hospital, Taiwan; bStrategy Planning Office,
Paochien Hospital, Taiwan; cCenters for Disease Control, Taiwan;
dDepartment of Health, Pingtung City Government, Taiwan
Purpose: Through this study to understand the status and efficacy of imple-
mentation of latent tuberculosis infection (LTBI) treatment program in our
hospital during 3 years period.
Methods: Including cases fit the criteria for national LTBI treatment program
from 2011 to Aug. 2014 under 13 years/old, through descriptive statistics to
understand the current status and efficacy in our hospital.
Results: The total number of cases exanimated in our hospital was 657, and
numbers fit the criteria for inclusion was 545 (82.9%). Positive tuberculin skin
test (TST) within first month was 190 cases (35%), and positive conversion at
the third month 139 cases (39%), totally 329 cases need to be treat for LTBI.
Family accepted to start LTBI treatment was 230 (85%), and the number that
should completed treatment at the end of this study was 203, and actual
completed treatment was 200 (98.5%).
Conclusion: Taiwan is country with high burden of TB, the treatment of
latent tuberculosis infection is an important strategy to further reducing
tuberculosis occurrence. During study period, we found 2 new TB cases via
contact screening in 2011, and 3 cases had side effect of itchy skin. We think
detailed and repeat education to the families with comprehensive case man-
agement and follow-up is the most important methods to improve the
compliance and efficacy of LTBI treatment program.
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SALVAGE THERAPY FOR REFRACTORY PULMONARY TUBERCULOSIS BY
TREATING CMV PNEUMONIA: A CASE REPORT
Mei-Yu Su a, Wen-Liang Yu a,b. aDepartment of Intensive Care Medicine,
Taiwan; bChi-Mei Medical Center, Tainan City, Taiwan
Purpose: Cytomegalovirus (CMV) infection occurs in 0 to 36% of critically ill
patients, mostly between 4 and 12 days after intensive care units (ICUs)
admission. Co-infection of miliary tuberculosis and CMV infection was re-
ported in Taiwan. We report a case of pulmonary tuberculosis (TB) with
delayed negative conversion of acid-fast bacilli probably due to co-infection
of CMV.
Case report: A 66-year-old man of liver cirrhosis suffered from respiratory
distress. Laboratory data showed leukocytosis (WBC: 19,900/mL); and C-
reactive protein, >250 mg/L. Chest CT showed suspicious TB. Acid-fast stain
(AFS) showed positive (4+). He was admitted to intensive care unit (ICU) on
July 29, 2014. He received endotracheal tube insertion with mechanical
ventilator use due to respiratory failure. CXR showed multiple opacities
were noticed in bilateral lung fields, compatible with TB infection. Antibi-
otics with Tazocin and anti TB with rifater and ethambutol were given.
Anti-TB therapy changed to rifinah and pyrazinamide due to liver function
impairment. Streptomycin was given from August 23 to September 17,
2014, due to persistent positive AFS. MTB Quantitative PCR showed 107
CFU/mL and no RIF Resistance. Blood and sputum CMV-PCR showed positive,
CMV viral load showed 258 IU/mL. Aspergillus Ag showed 0.23 Index. Anti-
CMV treatment with ganciclovir iv was used for 2 weeks. MTB QuantitativePCR showed 107 CFU/mL and no RIF Resistance. Blood and sputum CMV-
PCR showed not detected, CMV viral load showed <137 IU/mL. Then valgan-
ciclovir po was used for 4 weeks for CMV pneumonitis. Left pneumothorax
happened and pig-tail was inserted from August 9 to August 25, 2014. He
was transferred to RCC due to ventilator dependent on August 25, 2014.
CXR showed no pneumothorax on October 14, 2014. Sputum AFS was still
positive and we added antibiotic with levofloxacin for pulmonary TB and
sputum culture showed Stenotrophomonas maltophilia. Minocin oral form
was prescribed for sputum. After treatment, lung condition got much
improvement. He was transferred to RCW for ventilator department.
Conclusion: CMV co-infection could be considered for patients with refrac-
tory pulmonary TB and anti-CMV therapy may improve clinical outcome.PS 2-526
RITUXIMAB THERAPY IN 3 PATIENTS WITH DISSEMINATED NON-
TUBERCULOUS MYCOBACTERIAL INFECTION AND CONCURRENT ANTI-
IFN-g AUTOANTIBODIES
Wen-Chi Huang a, Jing-Ya Ding b, Ming-Chung Wang c, Jien-Wei Liu a,
Yi-Chun Chen a, Chih-Yu Chi d, Cheng-Lung Ku b, Chen-Hsiang Lee a.
aDivision of Infectious Diseases, Department of Internal Medicine,
Kaohsiung Chang Gung Memorial Hospital, Taiwan; bGraduate Institute of
Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan;
cDivision of Hematology, Department of Internal Medicine, Kaohsiung Chang
Gung Memorial Hospital, Taiwan; dSection of Infectious Diseases,
Department of Internal Medicine, China Medical University Hospital,
Taichung, Taiwan
Purpose: Autoantibodies against IFN-g is an emerging medical issue and linked
to disseminatedmycobacterial infections and other opportunistic infections in
the Southeast Asia. The origin of these autoantibodies is unclear; however, the
majority of affected patients share specificHLA class II alleles and this observa-
tion suggests a common mechanism in the production of auto-antibodies may
exist. Persistent or refractory infection seems to be the consequence of pa-
tients with disseminated non-tuberculous mycobacterial (NTM) infection and
concurrent anti-IFN-g autoantibodies even received anti-NTMantibiotics treat-
ment. Depletion of autoantibody to IFN-g by rituximab (anti-CD20) therapy
were been reported in some patients and they had clinical and laboratory evi-
dence of clearance of infection and diminished anti-IFN-g autoantibody. How-
ever, more evidences are required to show the efficacy and cost-effectiveness
of B cells depletion therapy in this disease.
Methods: We presented clinical courses of 3 patients (P1-3) with dissemi-
nated NTM infection and concurrent anti-IFN-g autoantibodies. Besides stan-
dard anti-NTM antibiotics treatment, they all received four doses of
rituximab therapy. The titers of anti-IFN-g auto-antibodies, ex vivo IL-
12p40 production in whole blood stimulated by IFN-g, inflammatory titers,
and clinical response in these 3 patients after rituximab therapy were
analyzed.
Results: P1 and P2 showed no significant difference of anti-IFN-g autoanti-
body titer in blocking assay (efficacy 50%) and had no response to exogenous
IFN-g stimulation in whole blood samples after received the rituximab ther-
apy. However, P3 had decreased the blocking titer and showed a significant
response to endogenous IFN-g activation in term of IL-12p40 production. Un-
expectedly, all 3 patients presented with shrinkage sizes of involved lymph
nodes by computer tomography (CT) study despite of consistent autoanti-
bodies levels in P1 and P2. P1 and P3 had continued anti-NTM antibiotics
treatment for 19 months and 30 months, respectively. P2 had cutaneous
NTM infection and disappeared 2 months after rituximab therapy, when
completed 3-month anti-NTM antibiotics. However, P2 had recurrence of
cutaneous lesions 5 months after discontinuing antibiotics. P3 had cervical
spondylitis involving C5 and C6 with compression signs around 6 months after
rituximab therapy. CT-guide biopsy showed negative culture for NTM, indi-
cated immune reconstitution syndrome-related progressive of symptoms,
rather than recurrence of NTM infection.
Conclusion: We showed here the clinical benefit of rituximab therapy in
combined with antibiotic regime in three patients with disseminated NTM
infection and concurrent anti-IFN-g autoantibodies. The improvement of
clinical signs might not associate with the decreasing of anti-IFN-g autoanti-
bodies measured in vitro. Short-course regime of rituximab therapy might
have good efficacy and cost-effectiveness to treat this disease.
